Nalaganje...

TAMI-52. G-CSF SECRETED BY EPIGENETICALLY REPROGRAMMED MUTANT IDH1 GLIOMA STEM CELLS, REVERSES THE MYELOID CELLS’-MEDIATED IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT

Mutation in isocitrate dehydrogenase (mIDH) is the main genetic lesion that defines clinical glioma subtypes and prognosis. This gain of function mutation is associated with the production of the oncometabolite, R-2-hydroxyglutarate, that inhibits α-ketoglutarate dependent enzymes such as TET2 and t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Alghamri, Mahmoud, Avvari, Ruthvik, Thalla, Rohit, Zhang, Li, Ventosa, Maria, Taher, Ayman, Núñez, Felipe, Heth, Jason, Orringer, Daniel, Lowenstein, Pedro, Castro, Maria
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651463/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.939
Oznake: Označite
Brez oznak, prvi označite!